Skip to main content
AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
13.05
+0.09 (0.69%)
At close: Nov 20, 2024, 4:00 PM
12.96
-0.09 (-0.69%)
After-hours: Nov 20, 2024, 7:02 PM EST

AVITA Medical Revenue

AVITA Medical had revenue of $19.55M in the quarter ending September 30, 2024, with 43.25% growth. This brings the company's revenue in the last twelve months to $60.04M, up 32.24% year-over-year. In the year 2023, AVITA Medical had annual revenue of $50.14M with 45.68% growth.

Revenue (ttm)
$60.04M
Revenue Growth
+32.24%
P/S Ratio
5.59
Revenue / Employee
$290,048
Employees
207
Market Cap
342.30M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202350.14M15.72M45.68%
Dec 31, 202234.42M1.40M4.23%
Dec 31, 202133.03M3.79M12.98%
Jun 30, 202129.23M14.97M104.95%
Jun 30, 202014.26M8.79M160.56%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cross Country Healthcare 1.45B
Viemed Healthcare 214.30M
Kamada 158.38M
Codexis 64.45M
Semler Scientific 58.94M
CVRx, Inc. 47.26M
Aclaris Therapeutics 27.08M
XOMA Royalty 21.61M
Revenue Rankings

RCEL News

More News